Hepatic Cell News Volume 5.28 | Jul 30 2021

    0
    13






    2021-07-30 | HCN 5.28


    Hepatic Cell News by STEMCELL Technologies
    Vol. 5.28 – 30 July, 2021
    TOP STORY

    Super Enhancer Regulation of Cytokine-Induced Chemokine Production in Alcoholic Hepatitis

    Researchers explored the mechanistic role of super-enhancers linking cytokine TNFα with chemokine amplification in alcoholic hepatitis.
    [Nature Communications]

    Full Article


    Dr. Kristina McBurney and Leanna Bedell discuss how you can use social media to advance your scientific career. Watch now.
    PUBLICATIONSRanked by the impact factor of the journal

    UBA6 and NDFIP1 Regulate the Degradation of Ferroportin

    A HepG2 cell line, which inducibly expressed ferroportin-GFP, was established to test the ability of siRNAs directed against components of the ubiquitin system to prevent BMP6- and exogenous hepcidin-induced ferroportin degradation.
    [Haematologica]

    Abstract

    SMYD3 Promotes Hepatocellular Carcinoma Progression by Methylating S1PR1 Promoters

    Researchers reported that SET and MYND domain-containing protein 3 (SMYD3) expression in hepatocellular carcinoma (HCC) was an independent prognostic factor for survival and promoted the proliferation and migration of HCC cells.
    [Cell Death & Disease]

    Full Article

    BH3-Only Protein Expression Determines Hepatocellular Carcinoma Response to Sorafenib-Based Treatment

    In the presence of NOXA, BIM-deficient hepatocellular carcinoma cells could be in turn strongly sensitized for cell death induction by the combination of sorafenib with TNF-related apoptosis-inducing ligand .
    [Cell Death & Disease]

    Full Article

    Downregulation of TMEM220 Promotes Tumor Progression in Hepatocellular Carcinoma

    Through overexpressing TMEM220 in hepatocellular carcinoma cell lines, scientists found that the proliferation of cancer cells was significantly slowed down and metastasis was significantly reduced.
    [Cancer Gene Therapy]

    Abstract

    TRIB2 Desensitizes Ferroptosis via βTrCP-Mediated TFRC Ubiquitiantion in Liver Cancer Cells

    Investigators identified the role of tribbles homolog 2 (TRIB2) to relieve oxidative damage via reducing the availability of ubiquitin that was essential for the ubiquitination and subsequent degradation of glutathione peroxidase 4.
    [Cell Death Discovery]

    Full Article

    Circular Noncoding RNA hsa_circ_0005986 as a Prognostic Biomarker for Hepatocellular Carcinoma

    Scientists evaluated the expression of a recently identified circular RNA, hsa_circ_0005986; determined its clinical significance; and evaluated its potential as a biomarker of hepatocellular carcinoma.
    [Scientific Reports]

    Full Article

    Low Serum Magnesium Concentration Is Associated with the Presence of Viable Hepatocellular Carcinoma Tissue in Cirrhotic Patients

    In a subset of 94 patients with hepatocellular carcinoma (HCC), a linear mixed effects model adjusted for confounders showed that serum magnesium at diagnosis of HCC was lower than before diagnosis of the tumor.
    [Scientific Reports]

    Full Article

    Photocrosslinkable Liver Extracellular Matrix Hydrogels for the Generation of 3D Liver Microenvironment Models

    Scientists explored the efficacy of two protocols to decellularize porcine liver tissue using varying combinations of commonly used chemical agents such as Triton X-100, Sodium Dodecyl Sulphate and ammonium hydroxide.
    [Scientific Reports]

    Full Article

    Explore virtual support and resources to stay productive and connected with your field.
    REVIEWS

    The Immunological and Metabolic Landscape in Primary and Metastatic Liver Cancer

    Investigators discuss how the hepatic microenvironment adapts to pathologies characterized by chronic inflammation and metabolic alterations. They illustrate how these immunological or metabolic changes alter immunosurveillance and thus hinder or promote the development of primary liver cancer.
    [Nature Reviews Cancer]

    Abstract

    Metabolic Hallmarks of Liver Regeneration

    The authors highlight how lipids, carbohydrates, and proteins dynamically change and orchestrate liver regeneration. They discuss translational studies in which metabolic intervention has been used to treat chronic liver diseases.
    [Trends in Endocrinology and Metabolism]

    Abstract

    INDUSTRY AND POLICY NEWS

    Arrowhead Pharmaceuticals Receives Breakthrough Therapy Designation from US FDA for ARO-AAT for the Treatment of Alpha-1 Antitrypsin Deficiency Associated Liver Disease

    Arrowhead Pharmaceuticals, Inc. announced that it was granted Breakthrough Therapy designation by the US FDA for ARO-AAT, also known as TAK-999, the company’s second-generation investigational RNA interference therapeutic being co-developed with Takeda Pharmaceutical Company Ltd. as a treatment for the rare genetic liver disease associated with alpha-1 antitrypsin deficiency.
    [Arrowhead Pharmaceuticals, Inc.]

    Press Release

    FEATURED EVENT

    Healthy Aging

    May 25 – 27, 2022
    Hinxton, England, United Kingdom

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral fellow – Bile Duct Immunology

    University of Oslo – Oslo, Norway

    Postdoctoral Fellow – Fatty Liver Disease

    Beckman Research Institute of City of Hope – Duarte, California, United States

    Postdoctoral Fellow – Cell Biology of Liver Metabolism

    Helmholtz Zentrum München – Munich, Germany

    Postdoctoral Fellowship – Fatty Liver Disease

    Johns Hopkins University School of Medicine – Saint Petersburg, Florida, United States

    Postdoctoral Associate – Liver Cancer

    University of Minnesota – Austin, Minnesota, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter